21647 ⎘
Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups -
Adipose-derived stem cells for tissue regeneration and wound healing
#21902Allogeneic and xenogeneic transplantation
#21903Transungual device
#21904Oncolytic adenovirus armed with therapeutic genes
#21905Recombinant double-stranded RNA phages and uses thereof
#21906Method for the treatment of myelodysplastic syndromes using cyclopropanecarboxylic acid {2-[1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-OXO-2,3-dihydro-1 H-isoindol-4-yl}-amide
#21907Method for treating urushiol induced contact dermatitis
#21908Skin material for external use and antiprutiric agent for external use and wrinkle-instrument using the same
#21909Composition for enhancing oral health
#21910Nasal spray steroid formulation and method
#21911Use of secretin-receptor ligands in treatment of cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD)
#21912Synergistic combination comprising roflumilast and an anticholinergic agent selected from ipratropium, oxitropium and tiotropium salts for the treatment of respiratory diseases
#21913Fluid wound dressing comprising partially cured polyurethane
#21914Use of a pparalpha agonist and metormin for decreasing the serum triglycerides
#21915Use of proteases for decomposing allergens
#21916Bis(thio-hydrazide amides) for increasing Hsp70 expression
#21917Skin lightening composition
#21918Medicaments for the Treatment or Prevention of Fibrotic Diseases
#21919Kynurenine 3-hydroxylase inhibitors for the treatment of diabetes
#21920Method for treating HIV infection through co-administration of tipranavir and GW695634
#2192117β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
#21922Combination therapy
#21923Synergistic combination comprising roflumilast and formoterol
#21924Combination product of inhibitor of the src family of non-recetpor tyrosine kinases and gemcitabine
#21925Compositions for affecting weight loss
#21926Combinations and methods for headaches
#21927Use of a combination of dppe with other chemotherapeutic agents for the treatment of breast cancer
#21928Combination effective for the treatment of impotence
#21929Use of selected CGRP-antagonists in combination with other antimigraine drugs for the treatment of migraine
#21930Compositions comprising multiple bioactive agents, and methods of using the same
#21931Composition comprising a combination of an aromatase inhibitor, a progestin and an oestrogen and its use for the treatment of endometriosis
#21932Hypocholesteremic preparations containing phytostenolesters of conjugated fatty acids, and methods of reducing serum cholesterol levels using the same
#21933Anti-microbial agents derived from methionine sulfoximine analogues
#21934Xanthurenic acid derivative pharmaceutical compositions and methods related thereto
#21935Potassium or sodium salt of (-)-2-(4-hydroxyphenyl)ethyl!-thio-3-'4-{4-'(methzlsulfonzl)oxy !phenoxy}phenyl!propanoic acid and their use in medicine
#21936Parasiticidal composition
#21937Nutrient pharmaceutical formulation comprising polyphenols and use in treatment of cancer
#21938TNF receptor and steroid hormone in a combined therapy
#21939Leuprolide acetate and acetylcholinesterase inhibitors or NMDA receptor antagonists for the treatment of alzheimer's disease
#21940Cholinergic modulation of microglial activation via alpha-7 nicotinic receptors
#21941Method of treating cancer
#21942Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment of prevention of gastric toxicity
#21943Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity
#21944Bioavailability/bioefficacy enhancing activity of and extracts and fractions thereof
#21945Supplement foods and pharmaceuticals
#21946Composition comprising a rice protein hydrolysate and an agent for increasing glycosaminoglycan synthesis
#21947Morinda citrifolia based compositions and methods for inhibiting xanthine oxidase
#21948Methods and compositions for weight management and mood enhancement
#21949Compositions and methods for treating gynecological disorders
#21950Notoginseng saponin intravenous injection and the method for preparing this injection
#21951Synergistic antipyretic formulation
#21952Herbal formulation as memory enhancer in Alzheimer condition
#21953Anti-allergic herbal formulation
#21954Herbal nutritious chocolate formulation and process for preparation thereof
#21955Herbal formulation for the treatment of piles
#21956Herbal formulation useful as local anesthetic
#21957Health promoting functional foods fortified with herbs
#21958Anti-arthritic herbal composition and method thereof
#21959Self-preserved ophthalmic pharmaceutical compositions containing tobramycin
#21960Methods and compositions for weight management and mood enhancement
#21961Methods of treatment of inflammatory diseases
#21962Antimicrobial resin composition
#21963Oral compositions containing oxidized camellia
#21964P-glycoprotein inhibitor comprising octilonium bromide as an effective ingredient
#21965Synergistic combination kit of alpha,beta-arteether, sulfadoxin and pyrimethamine for treatment of severe/multi-drug resistant cerebral malaria
#21966Pharmaceutical compositions containing abiguanide-glitazone combination
#21967Zinc-based compositions and methods of use
#21968Composition for topical treatment of mixed vaginal infections
#21969Anesthetic composition for topical administration comprising lidocaine, prilocaine and tetracaine
#21970Compositions of UCP inhibitors, Fas antibody, a fatty acid metabolism inhibitor and/or a glucose metabolism inhibitor
#21971Recombinant A2-specific TNFα-specific antibodies
#21972Cytochrome P450 enzyme complexes and methods of treatment using the same
#21973Composition of biochemical compounds involved in bioenergy metabolism of cells and method of use
#21974Platelet gel comprising platelet-rich plasma, platelet activator and polymer
#21975Methods and compositions for treating congestive heart failure
#21976Veterinary protocol for cellular regeneration
#21977Bacteriophage for the treatment of bacterial biofilms
#21978Recombinant adenoviral vectors and methods of use
#21979Method of reducing oral tissue inflammation using magnolia extract
#21980Oral care compositions containing a eucalyptus extract
#21981Buccal cavity treatment composition and corresponding uses thereof
#21982Method of the administration of drugs with binding affinity for plasma protein and preparation to be used in the method
#21983Incontinence treating sporting outfits
#21984Anti-cigarette herbal formulation as an antidote to tobacco
#21985Anthranilic acid derivatives as inhibitors of 17β-hydroxysteroid dehydrogenase 3
#21986Cardiovascular compositions
#21987Compositions for inhibition of necrosis induced by a neurotrophin
#21988Use for pharmaceutical composition
#21989Comprehensive pharmacologic therapy for treatment of obesity
#21990Method for treating HIV infection through co-administration of tipranavir and SCH-417690
#21991Method for treating HIV infection through co-administration of tipranavir and darunavir
#21992Pyrazine based inhibitors of glycogen synthase kinase 3
#21993Compound preparation for dizziness
#21994Use of imatinib (glivec,sti-571) to inhibit breast cancer resistance protein (BCRP)-mediated resistance to therapeutic agents
#21995Methods of treating tumors
#21996Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
#21997Compositions of a cyclooxygenase-2 selective inhibitor and a calcium modulating agent for the treatment of pain, inflammation or inflammation mediated disorders
#21998Combination therapy for treating heart disease
#21999Use of sulfonamide-including compounds in combination with angiogenesis inhibitors
#22000Anti-obesity compositions
#22001Treatment of refractory cancers using NA+/K+ ATPase inhibitors
#22002Methods, assays and compositions for treating retinol-related diseases
#22003Antiviral oligonucleotides
#22004Composition for improving blood fluidity
#22005Combinatorial chemotherapy treatment using Na+/K+ ATPase inhibitors
#22006Method for treating pain in trigeminal neuralgia
#22007Agent that retards transformation of hormone-dependent cancer to non-hormone-dependent cancer
#22008BLy antagonists and uses thereof
#22009Unitary combination of FSH and hCG
#22010Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier
#22011Process for producing sterile suspensions of slightly soluble basic peptide complexes, sterile suspensions of slightly soluble basic peptide complexes, pharmaceutical formulations containing them, and the use thereof as medicaments
#22012Therapeutic formulations for the treatment of beta-amyloid related diseases
#22013Method for treatment of HIV infection
#22014Gallocatechin gallate-containing composition
#22015Hop acids as a replacement for antibiotics in animal feed
#22016Treatment of inflammatory bowel disease
#22017Breast health supplement and detoxification preparations
#22018Synergistic composition for the treatment of diabetes mellitus
#22019Agents against microorganisms containing patchouli oil, patchouli alcohol and/or the derivatives thereof
#22020Anti-microbial composition and methods of use thereof
#22021Anti-allergy composition and related method
#22022External preparation for improving blood flow
#22023Cosmetic composition
#22024Herbal supplement for cognitive related impairment due to estrogen loss
#22025Use of natural plant extracts in cosmetic compositions
#22026Weight loss composition and formulation
#22027Compositions including iron
#22028Compositions useful to treat ocular neovascular diseases and macular degeneration
#22029Phosphate binder with reduced pill burden
#22030Leukotriene and integrin inhibitor combination and treatment method
#22031Dosage form containing diphenhydramine and another drug
#22032Oxygenating agents for enhancing host responses to microbial infections
#22033Agents which regulate, inhibit, or modulate the activity and/or expression of formyl peptide receptors as a unique means to both lower intraocular pressure and treat glaucomatous retinopathies/optic neuropathies
#22034Methods for treatment of inflammatory diseases
#22035Antiallergic agent
#22036Peptide constructs for treating disease
#22037Preventives/remedies for cancer
#22038Treatment of diabetes using antibodies to IL-23, IL-23 receptor and IL-17
#22039Lymphotoxin beta receptor agents in combination with chemotherapeutic agents
#22040FIBRIN MATERIAL AND METHOD FOR PRODUCING AND USING THE SAME
#22041Fibrin cell supports and methods of use thereof
#22042Additive for an animal feed
#22043Enzymatic treatment of retinitis pigmentosis
#22044Therapeutic platelets and methods
#22045Use of marrow-derived glial progenitor cells as gene delivery vehicles into the central nervous system
#22046Composition and method for improving function of embryonic kidney transplants
#22047Compositions and methods for promoting hair growth
#22048Treatment of cancer by simultaneous inhibiton of BRAF and restoration or mimicry of p16INK4A activity
#22049Combined treatment with interferon-alpha and an epidermal growth factor receptor kinase inhibitor
#22050Ophthalmic compositions comprising Aloe Vera
#22051Nail restructuring compositions for topical application
#22052Phototherapy compositions and methods
#22053Oral treatment compositions containing an anti-adhesion agent, antibacterial agent and incompatible compound
#22054Method to promote oral health in companion animals
#22055Oral and dental composition
#22056Remedies for allergic diseases
#22057Rapidly absorbed liquid compositions
#22058Method of using adapalene in acne maintenance therapy
#22059Methods of treating tardive dyskinesia and other movement disorders
#22060Medium-chain length fatty acids, glycerides and analogues as stimulators of erythropoiesis
#22061Deguelin as a chemopreventive agent for lung cancer
#22062Medicinal composition and method for treating malignant tumor and utilization thereof
#22063CETP inhibitors in combination with antihypertensive agents and uses thereof
#22064Use of pagoclone for the treatment of social anxiety disorder
#22065Cell migration inhibiting compositions and methods and compositions for treating cancer
#22066Method for treating HIV infection through co-administration of tipranavir and reverset
#22067Pyrrolo [2,3-d] pyrimidine and their use as purinergic receptor antagonists
#22068Use of radical-scavenging compounds for treatment and prevention of NO-dependent microcirculation disorders
#22069Novel formulations of opioid-based treatments of pain comprising substituted 1,4-di-piperidin-4-yl-piperazine derivatives
#22070Use of 4-pyridylmethyl-phthalazine derivatives for the manufacture of a medicament for the treatment of myelodysplastic syndromes
#22071Maternal multi-nutrient against diabetes-related birth defects
#22072Adenosine A2a receptor antagonists for the treatment of extra-pyramidal syndrome and other movement disorders
#22073Lactam glycogen phosphorylase inhibitors and method of use
#22074Novel rho inhibitors
#22075Method for treatment of dysmenorrhea
#22076Compositions of nicotinic agonists and therapeutic agents and methods for treating or preventing diseases or pain
#22077Method for monitoring the effectiveness of teracycline in the treatment of asthma
#22078Intermediates for imidazonaphthyridines
#22079Pharmaceutical compositions comprising CB1 cannabinoid receptor antagonists and potassium channel openers for the treatment of obesity and related conditions
#22080Methods for the administration of amifostine and related compounds
#22081Compositions containing a combination of a creatine compound and a second agent
#22082Selected betaines and their uses
#22083Charged phospholipid compositions and methods for their use
#22084Use of hyaluronic acid or its derivatives to enhance delivery of antineoplastic agents
#22085Pharmaceutical formulation of decitabine
#22086Methods and compositions for modulating drug activity through telomere damage
#22087Combination of a taxane and a cyclin-dependent kinase
#22088Povidone-containing carriers for polypeptide growth factors
#22089Pharmacokinetic and pharmacodynamic modeling of erythropoietin administration
#22090Composition for enzyme inhibition
#22091Lipase-containing composition and methods of use thereof
#22092Comprehensive virus disinfecting strategy and methods for making a preventive anti-virus medical product
#22093Use of c-Jun or c-Jun activating agents such as UV or c-Jun N-terminal kinases (JNKs) for treating cancer
#22094Protein-containing preparation which can be biotechnologically produced, method for the production thereof, and use of the same as a food ingredient
#22095Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response
#22096Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response
#22097Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response
#22098Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response
#22099Preparation for the relief of disease
#22100Agent for increasing granulocyte macrophage colony stimulating factor
#22101Compositions of S-adenosyl-L-methionine
#22102Anti-inflammatory formulations
#22103Medicament for treatment of cancer and other diseases
#22104Compositions for treatment of inflammatory diseases
#22105Methods for inhibiting STAT3 signaling in immune cells
#22106Synergistic antimicrobial ophthalmic and dermatologic preparations containing chlorite and hydrogen peroxide
#22107L-histidine in ophthalmic solutions
#22108Composition for treating psoriasis
#22109Sustained improver of muscular fatigue
#22110Process of making flowable hemostatic compositions and devices containing such compositions
#22111Combination of immuno gene therapy and chemotherapy for treatment of cancer and hyperproliferative diseases
#22112Methods and related compositions for reduction of fat and skin tightening
#22113Wound care device having fluid transfer properties
#22114Method and composition for reducing cravings for a craved substance
#22115Method and composition for lowering cholesterol
#22116Anti-angiogenic compositions and methods of use
#22117Drug delivery systems for the prevention and treatment of vascular diseases
#22118Inhibition of mammalian hair growth
#22119Controlled-Release of Cosmetic and Pharmaceutical Agents via Osmotic Nano-Diffusion from Zeolite Cage Complexes
#22120Topical numbing composition for laser therapy
#22121Compositions based on polysaccharides and protein C and methods of using the same for preventing and treating sepsis and other conditions
#22122Use of substance P for mobilization of Mesenchymal stem cells or proliferation of Mesenchymal stem cells and for wound healing or facilitating wound healing
#22123Compositions containing macrophages and uses thereof
#22124Method of cell therapy using fused cell hybrids
#22125Rapamycin and il-10 for the treatment of immune diseases
#22126Composition for treating and/or preventing periodontal disease
#22127Pharmaceutical foam
#22128Methods of treating humans undergoing injection of a contrast agent
#22129Devices and compositions containing boron and silicon for use in neutron capture therapy
#22130Nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases
#22131Agentfor reducing side effects of diclofenac
#22132Use for deferiprone
#22133Use of medium chain triglycerides for the treatment and prevention of Alzheimer's disease and other diseases resulting from reduced neuronal metabolism
#22134Method for treating HIV infection through co-administration of tipranavir and UK-427,857
#22135Flumazenil for the treatment of cocaine dependency
#22136Combination of organic compounds
#22137Use and application of a pharmaceutical composition containing a mixture of natural- origin heterocyclical guanidine, for cosmetology, wound healing, focal dystonia and muscular spasm- related clinical pathologies
#22138Tablet comprising efletirizine and pseudoephedrine
#22139Chemical compounds
#22140Combination of a nitrogen mustard analogue and imatinib for the treatment of chronic lymphocytic leukemia
#22141Therapeutic treatment
#22142Co-administration of dehydroepiandrosterone (DHEA) congener with parthenolide for treating inflammation
#22143Pharmaceutical formulation
#22144Pharmaceutical application of 15- or 16-substituted testosterone analogues
#22145Composition containing an association of aspirin and an anti-Xa oligosaccharide and use of an anti-Xa oligosaccharide optionally in combination with aspirin
#22146Extraction and purification method for cereal beta-glucan
#22147Combination preparation of hyaluronic acid and at least oe local anesthetic and the use thereof
#22148Methods for reducing the side effects associated with mirtzapine treatment
#22149Use of SERP-1 as an antiplatelet agent
#22150Nogo, caspr, f3 nb-3 useful in the treatment of injury and disease to the central nervous system
#22151Prevention and/or treatment of inflammatory bowel disease using pyy or agonists thereof
#22152Method of improing the growth performance of an animal
#22153Dalfopristine/quinupristine combinations with cefpirome
#22154Mucus formulation for mucosal surfaces and uses thereof
#22155Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome
#22156Hepatocurative effect of Emblica officinalis against CYP 450 bio-activation hepatotoxicity of drugs
#22157Antioxidant dietary supplement compositions and methods for maintaining healthy skin
#22158TNF-alpha production inhibitor comprising kavalactone as an active ingredient
#22159Pharmaceutical compositions comprising cereal beta (1-3) beta (1-4) glucan
#22160Dietary supplement
#22161Methods and compositions for P2X receptor calcium entry channels and other calcium entry mechanisms
#22162Formulation which can be administered gastrointestinally, containing green tea extract and an no donor
#22163Anti-angiogenic compositions and methods of use
#22164Transdermal delivery system
#22165Method for oxygen treatment of intact skin
#22166Preparation comprising 1,3 and/or 1,6 beta glucans for the treatment of infections and inflammations in animals
#22167Drug-eluting stents coated with non-nucleotide P2Yreceptor antagonist compound
#22168Topical parasiticide formulations and methods of treatment
#22169Compositions and methods for WT1 specific immunotherapy
#22170Methods of treating rheumatoid arthritis with anti-TNF antibodies
#22171Treatment for alzheimer's disease and related conditions
#22172Method and composition for regulating the activity of regulatory t cells
#22173Mixture preparation for enhancing absorption of immunoglobulins in postnatal domestic mammals, and the method thereof
#22174Methods and compositions for targeting proteins across the blood brain barrier
#22175Compositions and methods for treating pancreatic insufficiency
#22176Methods and compositions for treatment of free radical injury
#22177Combined regulation of neural cell production
#22178Methods and compositions for tissue regeneration
#22179Cancer therapeutic compositions
#22180Vaccine immunotherapy for immune suppressed patients
#22181Neoadjuvant genetic compositions and methods
#22182Bioabsorbable polymers
#22183Composition for treating hair and scalp and method for preparing same
#22184Controlled delivery system of antifungal and keratolytic agents for local treatment of fungal infections of the nail and surrounding tissues
#22185Solution forms of cyclodextrins for nasal or throat delivery of essential oils
#22186Salmeterol superfine formulation
#22187Isoflavone concentrates, as well as methods for their production
#22188Methods and compositions for administration of iron for the treatment of restless leg syndrome
#22189Ready-for-complexation composition
#22190Folate based composition for treatment of the cardiovascular system
#22191Combined use of carnosinase inhibitor with l-carnosines and composition
#22192Functional foods/drinks containing antiallergic component
#22193Method and composition for the treatment of muscular-skeletal and related afflictions
#22194Anti-diabetic extract isolated from and , and method of using same
#22195Calcium lactate and whey permeate for lowering the triglyceride level
#22196Nanoparticles for targeting hepatoma cells
#22197Gastric acid secretion inhibiting composition
#22198Fluid application device and method
#22199SAFE, ECO-FRIENDLY, HEALTH PROTECTIVE HERBAL COLOURS AND AROMA USEFUL FOR COSMACEUTICAL APPLICATIONS
#22200Ophthalmic ointment composition comprising a drug, an ointment base and a solubilizing/dispersing agent